Recent advances in nuclear transfer technology for derivation of patient-specific stem ceils have opened up new avenues of" therapy for various human diseases. However, a major bottleneck is the severe shortage of human donor oocytes. Egg-sharing in retum for subsidized fertility treatment has been suggested as an ethically justifiable and practical solution to ease the shortage of donor oocytes both for derivation of nuclear transfer stem cells and assisted reproduction. However, it is envisioned that many patients would be more comfortable with their supernumerary oocytes going into derivation of nuclear transfer stem cells, rather than having another potential anonymous offspring in assisted reproduction. Nevertheless in more economically developed countries, fertility treatment is easily affordable to a large segment of the population, which reduces the pool of available egg-sharers. In less affluent countries, fertility treatment is often beyond the financial resources of most sub-fenile couples. Hence, a possible solution may be to allow egg-sharing across intemational borders. Potential egg-sharers would come from less economically-developed countries that are more in need of financial subsidies for sub-fertile couples seeking clinically assisted conception. This is ethically justifiable because it makes fertility treatment affordable to childless couples from poorer countries, while at the same time easing the shortage of donor oocytes in more affluent countries.
The recent advances in the derivation of nuclear transfer stem cells by Hwang and colleagues (Hwang et al.. 2004 (Hwang et al.. , 2005 , have generated worldwide interest and have opened up new avenues of therapy for various human disea.ses. However, the major bottleneck of this new technology is the severe shortage of human donor ooeytes, as well as the need to use them fresh immediately upon retrieval (Hwang et al.. 2005 : Stojkovic et al.. 2005 .
Egg-sharing in return lor sub.sidized lertility treatment has been suggested as an ethically justifiable and practical solution to ease the shortage of donor oocytes for both derivation of nuclear transfer stem cells (Heng. 2005) and assisted reproduction (Ahuja etal.. 2000) . Compared with the rampant commercialization that is associated with the direct sale and purchase of donor oocytes (Sauer. 1999) . egg-sharing appears to be more morally palatable. On the one hand, the financial burden for a childless couple is greatly eased, while on the other hand, cither new hope of conception is given to a barren woman (Ahuja et a!.. 2000) . or a new lease of life given to a terminally sick patient (Heng. 2005) . Because the therapeutic value of nuclear transfer stem cells has not yet been proven in human clinical trials, shared oocytes should preferably be allocated to assisted reproduction rather than therapeutic cloning. However. it is envisioned that patients would be more comfortable with their supernumerary oocytes going into derivation of nuclear transfer stem cells, rather than having another potential anonymous offspring in an unknown family. The question of donor and recipient anonymity in egg sharing is discussed in greater depth in the excellent review of Craft et al. (2005) .
Ethics, social, legal, counselling-tgg sharing across internation;]! hordcrs -BC HeniMore importantly, egg sharing minimizes medical risk by reducing the need to recruit oocyte donors from healthy women not seeking assisted conception (Rimington et al.. 2003) .
Furthermore, it must be noted that most couples that need o(x:ytc donation arc usually 10-15 years older than those who need either IVF or intracytoplasmic sperm injection (ICSI). It is often the case that oocyte recipients are highly educated dual-income professional couples who married late in life, due to pursuit of their educational or career goais in their younger days. Hence, the extra years of dual income give recipients a financial advantage that can be shared with younger couples.
Moreover, recent evidence would suggest that egg sharing does not significantly compromise the success of fertility treatment (Thum et ai.. 2003) , if judiciously managed. For exampie. potential egg-sharers may be narrowed down fo indications for male partner sub-fertility or to younger women with tubal blockage, who are likely to pnxluce excess supernumerary (X)cytes in response to gonadotrophin stimulation. In any case. all prospective egg-sharers must receive mandatory counselling and obtain enough informative consent material before any decision is made. Additionaliy, the patients, clinicians and scientists invoived shouid strictly follow reguiations and keep ciear documentation of all clinical and scientific procedures being perfonned.
Nevertheless, in more economically developed countries with higher median incomes, fertility treatment is easily affordable to a large segment of the popuiation. except for those in the iower income groups. Consequently, this reduces the pool of available egg sharers, which in turn translates to a severe shortage of donor txicytes for infertiie women in developed countries (Pennings. 2(K)1). At the same time in iess affluent countries, fertiiity treatment is often beyond the financiai resources of most sub-fertiie coupies (Serour cr o/.. 1991; Inhorn. 2003).
Hence, a possible solution may be to allow egg-sharing across intemational borders to ease the shortage of donor (wcytes for a.ssisted reproduction and the derivation of nuclear transfer stem cells. Potentiai egg-sharers would come from iess economitaiiy developed countries that are more in need of financiai subsidies for sub-fertile couples seeking clinicaiiy assisted conception. This is ethicaily justifiable because it makes fertility treatment affordable to chiidless couples from poorer countries, while at the same time easing the shortage of donor oocytes in more affluent countries where the technology of nuclear transfer for the derivation of patient-specific stem cells is currently being developed.
Because the prospective recipients of an intemational eggsharing scheme are usually financially better off than the prospective donors, they should be the ones taking the initiative to travel to a less affluent eountry. Alternatively, they could instead sponsor the travel and accommodation expenses of the prospective egg-sharer and her partner. The ready avaiiability of better medical facilities in tnore econotiiically developed countries couid be an additionai boon to sub-fertile coupies from poorer countries, where treatment faciiities are often substandard (Rojanasakul et al.. i994 ).
Certainly, it can be argued that such as system is akin to 'neocolonialism* and would be exploitative of childless couples from poorer countries. However, it must be remembered that it would be an even greater tragedy for such couples to remain childless for life simply because they do not have enough money to seek fertility treatment. Hence, egg sharing across international borders is therefore likely to bring much hope to many desperate couples from poorer countries.
To minimize phenotypic differences, intemational egg-sharing may be carried out between countries which share the same racial stock. For example, the richer countries of Western Furope can look to the less affluent countries of Eastern Europe and Russia for potential egg sharers; while in Asia, more affluent countries like Japan. South Korea. Singapore. Hong Kong and Taiwan can look towards mainland China, or even Vietnam. Certainly. egg sharing across international borders would be benellcial to both parties invoived. However, it must be noted that ijecause of cultural and reiigious differences between different countries, there are varying ethical standards and legislation that must first be addressed before such a scheme can be successfully implemented. 
Organization of biological clocks
Many clocks regulate biological systems (Gillette and Sejnowski. 2005). Diurnal rhythms, sleep patterns, cellular and molecular systems are all tightly regulated. They tbrm a small proportion of the total number of active timers. Instead of being studied in isolatioti. as now. chronobiology has emerged as a novel scientific subject and covers interactions among various clocks. Mitosis is regulated by genetic, cellular and molecular clocks (Johnson et at.. 2002) . Cells pass various amoutits of time in the successive stages ofthc cell cycle and key proteins. known as the cyclins, control cycle progression by means of phosphorylation. proteolysis and spatial targeting. Such decisions are made at specific check points which determine whether to proceed along specific pathways. This timing system may be influenced by other time keepers. Metabolic and mitotic systems are present in high-density cultures of human ceils, and the interface of these systems may be a general feature of clock-controlled systems. The cycle of cell division is basically a relaxation oscillator of embedded negative feed-back loops involving the cyclins.
The circadian clock has been studied in relation to cycles of cell division and metabolism. It involves an innate timekeeping system governing a cycle of rhythmic activity. It has a control point, like the cell cycle. located in the suprachiasmatic nucleus, which is where decisions are made about proceeding or abandoning the cycle. Its regulatory genes include BMAL. PERIOD, CRYPTOCHROME and CLOCK, which also regulate their own transcription. Feedback loops generating circadian time are based on the transcriptional-translational and post translational regulation of clock genes. Mice lacking some of these genes, e.g. per2. suffer frotn altered levels of cyclic regulators, e.g. cmyc. The mammalian cell cycle is also regulated by such clocks, and information on them is emerging from the use of microarrays at different stages of timing. Links between the circadian cycle and the metabolic cycle involve a cluster of genes encoding ratelimiting enzymes of intermediary metabolism. The sleepwake cycle involves two processes, the drive to sleep and wakefulness in relation to night and day. It is also related to energy stores in the brain where the sleep-wake cycle controls a cascade of oscillatory electrical activity.
Biological systems also adapt to long time scales, while seasonal rhythms regulate long-term behavioural and developmental changes. They may have evolved from earlier cyclic processes, e.g. opposing metabolic states imposed by the availability of solar eticrgy and lightinduced stress. External light and dark cycles could have interfaced with the circadian clock and with metabolic cycles, and physiological systems may then have been organized around these and other cycles as organisms became increasingly complex. Computer models have been designed to investigate these possibilities. They are needed to analyse the interelationships between numerous cyclic processes in relation to temporal and spatial scales.
